Samuel Kaffenberger
Clinical Associate Professor of Urology
Associate Chief Clinical Officer
Urology and Core Educational Lead
Cancer Center Administration
[email protected]

Available to mentor
Samuel Kaffenberger
Clinical Associate Professor
  • Center Memberships
  • Recent Publications
    • Center Memberships
    • Center Member
      Rogel Cancer Center
    Recent Publications See All Publications
    • Journal Article
      Financial Implications of Prostate Magnetic Resonance Imaging Without Contrast.
      Pockros B, Davenport M, Mead M, Talwar R, Kaffenberger S, Sekar R, Ibrahim A, Morgan TM. Urol Pract, 2024 Nov; 11 (6): 915 - 917. DOI:10.1097/UPJ.0000000000000646
      PMID: 39196665
    • Journal Article
      Integrative Drug Screening and Multiomic Characterization of Patient-derived Bladder Cancer Organoids Reveal Novel Molecular Correlates of Gemcitabine Response.
      Merrill NM, Kaffenberger SD, Bao L, Vandecan N, Goo L, Apfel A, Cheng X, Qin Z, Liu C-J, Bankhead A, Wang Y, Kathawate V, Tudrick L, Serhan HA, Farah Z, Ellimoottil C, Hafez KS, Herrel LA, Montgomery JS, Morgan TM, Salami SS, Weizer AZ, Ulintz PJ, Day ML, Soellner MB, Palmbos PL, Merajver SD, Udager AM. Eur Urol, 2024 Nov; 86 (5): 434 - 444. DOI:10.1016/j.eururo.2024.05.026
      PMID: 39155193
    • Journal Article
      Abstract A009: Integrative drug screening and multi-omic characterization of patient-derived bladder cancer organoids reveals novel molecular correlates of chemotherapy response
      Merrill NM, Kaffenberger SD, Bao L, Vandecan N, Goo LE, Apfel A, Cheng X, Qin Z, Liu C-J, Bankhead A, Wang Y, Kathawate V, Tudrick L, Serhan H, Farah Z, Ellimoottil C, Hafez KS, Herrel LA, Montgomery JS, Morgan TM, Salami SS, Weizer AZ, Ulintz PJ, Day ML, Soellner MB, Palmbos PL, Merajver SD, Udager AM. Clinical Cancer Research, 2024 May 17; 30 (10_Supplement): A009 - A009. DOI:10.1158/1557-3265.bladder24-a009
    • Proceeding / Abstract / Poster
      PD45-04 DOES DRE ADD VALUE TO THE AUA PROSTATE CANCER RISK STRATIFICATION?
      Krischak M, Kaffenberger S, Montgomery J, Palapattu G, Borza T, Semerjian A, Salami S, Morgan T, Stensland K. Journal of Urology, 2024 May; 211 (5S): e968 DOI:10.1097/01.ju.0001008792.09108.b4.04
    • Journal Article
      Extragonadal germ cell tumors: A clinicopathologic study with emphasis on molecular features, clinical outcomes and associated secondary malignancies.
      Abdulfatah E, Brown NA, Davenport MS, Reichert ZR, Camelo-Piragua S, Heider A, Huang T, Vaishampayan UN, Skala SL, Montgomery JS, Chinnaiyan AM, Kaffenberger SD, Bawa P, Shao L, Mehra R. Hum Pathol, 2024 Jun; 148: 41 - 50. DOI:10.1016/j.humpath.2024.04.015
      PMID: 38697270
    • Journal Article
      Development and application of a precision cell-free DNA (cfDNA) minimal residual disease (MRD) test to enable optimized treatment selection in patients with genitourinary (GU) cancers.
      Cooley D, Vaishampayan UN, Kaffenberger S, Drnek L, Johnson B, Lamb LE, Khazanov NA, Hovelson DH, Kwiatkowski K, Rhodes DR, Tomlins SA, Hafez K, Herrel LA, Montgomery JS, Gursky A, Udager AM, Morgan TM. Journal of Clinical Oncology, 2024 Feb 1; 42 (4_suppl): 473 - 473. DOI:10.1200/jco.2024.42.4_suppl.473
    • Journal Article
      Comparing Patient-reported Functional Outcomes After Radical Prostatectomy in Historical and Contemporary Practice.
      Singhal U, Hollenbeck BK, Kaffenberger SD, Salami SS, George AK, Skolarus TA, Montgomery JS, Wittmann DA, Miller DC, Wei JT, Palapattu GS, Montie JE, Dunn RL, Morgan TM. J Urol, 2023 Nov; 210 (5): 771 - 777. DOI:10.1097/JU.0000000000003646
      PMID: 37566643
    • Journal Article
      Spatial Heterogeneity of Glomerular Phenotypes Affects Kidney Biopsy Findings.
      Schaub JA, O'Connor CL, Dailey M, Hlynka AW, Chang Y, Postiff D, Kaffenberger SD, Palapattu GS, Gillespie BW, Hodgin JB, Shedden K, Bitzer M. Kidney360, 2023 Nov 1; 4 (11): 1598 - 1607. DOI:10.34067/KID.0000000000000283
      PMID: 37889598